Replies to post #728210 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Don't you think LP should've briefed her shareholders on the NICE timeline instead of folks here trying to figure it all out? 

[Lykiri]

OCTOBER 23, 2024

INDIANAPOLIS, Oct. 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for donanemab, an injection for intravenous infusion every four weeks to treat mild cognitive impairment and mild dementia due to Alzheimer's disease in eligible adults in Great Britain

https://investor.lilly.com/news-releases/news-release-details/lillys-kisunlatm-donanemab-azbt-receives-marketing-authorization

OCTOBER 24, 2024

MHRA approves donanemab…
…but NICE says it does not demonstrate value for the NHS

.
https://acnr.co.uk/mhra-approves-donanemab/